Terumo Corp stock (JP3443600006): valuation metrics in focus after steady Tokyo trading

Terumo Corp shares were little changed on the Tokyo Stock Exchange on 06/05/2026, leaving investors to focus on valuation metrics and the broader outlook for the Japanese medical technology group.

Terumo Corp shares were broadly stable in Tokyo trading on 06/05/2026, signaling a period of consolidation for the Japanese medical technology group as investors weigh its valuation against sector peers and long-term growth prospects.

According to the investors section of Terumo's global website, the stock last traded at 2,280.0 JPY on the Tokyo Stock Exchange on 06/05/2026, a move of 4.0 JPY or 0.18% for the day, on volume of 4,351,900 shares as of the 3:30 PM close in Japan, underlining modest price action but solid liquidity in its home market.

Japan remains the home base and primary listing venue for Terumo, and the Tokyo Stock Exchange quote in Japanese yen is the key reference point for many institutional investors assessing the company within the domestic medical devices and healthcare equipment universe.

While the daily percentage change of 0.18% on 06/05/2026 is small in absolute terms, the combination of an actively traded share and a sizable closing volume of 4,351,900 shares on the Tokyo Stock Exchange highlights that Terumo continues to attract attention from market participants seeking exposure to Japan's healthcare technology sector.

For international investors, Terumo's Japanese listing provides access to one of the country's recognized names in medical technology, and the 2,280.0 JPY closing level on 06/05/2026 is an important benchmark when translating valuation metrics into other currencies or comparing them to global peers.

As of: 05.06.2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Terumo
• Sector/industry: Medical devices and healthcare equipment
• Headquarters/country: Tokyo, Japan
• Core markets: Japan, North America, Europe, Asia-Pacific
• Key revenue drivers: Vascular and interventional systems, blood management and transfusion products, hospital and cardiac care solutions
• Home exchange/listing venue: Tokyo Stock Exchange (4543)
• Trading currency: JPY

Terumo Corp: core business model

Terumo Corp operates as a diversified medical technology group headquartered in Tokyo, focusing on devices and systems for cardiovascular care, hospital therapies and blood management that are sold to hospitals and clinics across major global healthcare markets.

Valuation metrics and multiples for Terumo Corp

With Terumo Corp stock closing at 2,280.0 JPY on the Tokyo Stock Exchange on 06/05/2026, investors paying close attention to valuation metrics are likely to analyze the share price in relation to earnings, cash flow and revenue to position the company within the broader Japanese medical device segment.

The last trade level of 2,280.0 JPY, combined with an end-of-day volume of 4,351,900 shares on 06/05/2026, suggests a market that is actively pricing Terumo's prospects in cardiovascular and hospital-care technologies, with valuation discussions often centering on how its multiples compare to other established Japanese and global medtech players.

Conclusion

The small 0.18% move in Terumo Corp stock to 2,280.0 JPY on the Tokyo Stock Exchange on 06/05/2026 leaves the market narrative focused less on day-to-day volatility and more on where the company's valuation multiples stand within the Japanese and global medtech landscape.

For investors monitoring the name, the combination of active trading volume of 4,351,900 shares and Terumo's role in cardiovascular and hospital-care technologies provides a framework to analyze how the current share price reflects expectations for long-term growth and profitability without relying on short-term price swings.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.